» Articles » PMID: 35528689

Functionalization of Theranostic AGuIX® Nanoparticles for PET/MRI/optical Imaging

Abstract

A novel trifunctional imaging probe containing a chelator of radiometal for PET, a NIR heptamethine cyanine dye, and a bioconjugatable handle, has been grafted onto AGuIX® nanoparticles a Michael addition reaction. The resulting functionalized nanoparticles have been fully characterized, radiolabelled with Cu, and evaluated in a mice TSA tumor model using multimodal (PET/MRI/optical) imaging.

Citing Articles

Recent Advances in Cu/Cu-Based Radiopharmaceuticals.

Krasnovskaya O, Abramchuck D, Erofeev A, Gorelkin P, Kuznetsov A, Shemukhin A Int J Mol Sci. 2023; 24(11).

PMID: 37298101 PMC: 10288943. DOI: 10.3390/ijms24119154.


Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology.

Pijeira M, Viltres H, Kozempel J, Sakmar M, Vlk M, Ilem-Ozdemir D EJNMMI Radiopharm Chem. 2022; 7(1):8.

PMID: 35467307 PMC: 9038981. DOI: 10.1186/s41181-022-00161-4.


Dual-Labelling Strategies for Nuclear and Fluorescence Molecular Imaging: Current Status and Future Perspectives.

Kubeil M, Martinez I, Bachmann M, Kopka K, Tuck K, Stephan H Pharmaceuticals (Basel). 2022; 15(4).

PMID: 35455430 PMC: 9028399. DOI: 10.3390/ph15040432.


Advanced Optical Imaging-Guided Nanotheranostics towards Personalized Cancer Drug Delivery.

Murar M, Albertazzi L, Pujals S Nanomaterials (Basel). 2022; 12(3).

PMID: 35159744 PMC: 8838478. DOI: 10.3390/nano12030399.


Targeted PET/MRI Imaging Super Probes: A Critical Review of Opportunities and Challenges.

Kastelik-Hryniewiecka A, Jewula P, Bakalorz K, Kramer-Marek G, Kuznik N Int J Nanomedicine. 2022; 16:8465-8483.

PMID: 35002239 PMC: 8733213. DOI: 10.2147/IJN.S336299.


References
1.
Pichler B, Judenhofer M, Pfannenberg C . Multimodal imaging approaches: PET/CT and PET/MRI. Handb Exp Pharmacol. 2008; (185 Pt 1):109-32. DOI: 10.1007/978-3-540-72718-7_6. View

2.
Li X, Zhang X, Li X, Chang J . Multimodality imaging in nanomedicine and nanotheranostics. Cancer Biol Med. 2016; 13(3):339-348. PMC: 5069837. DOI: 10.20892/j.issn.2095-3941.2016.0055. View

3.
Bouziotis P, Stellas D, Thomas E, Truillet C, Tsoukalas C, Lux F . Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapy. Nanomedicine (Lond). 2017; 12(13):1561-1574. DOI: 10.2217/nnm-2017-0032. View

4.
Thorp-Greenwood F, Coogan M . Multimodal radio- (PET/SPECT) and fluorescence imaging agents based on metallo-radioisotopes: current applications and prospects for development of new agents. Dalton Trans. 2011; 40(23):6129-43. DOI: 10.1039/c0dt01398f. View

5.
Anderson C, Ferdani R . Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research. Cancer Biother Radiopharm. 2009; 24(4):379-93. PMC: 2794299. DOI: 10.1089/cbr.2009.0674. View